A - Agilent Technologies, Inc.
| Previous Close | 69.59 |
| Open | 69.90 |
| Bid | 70.01 x 1000 |
| Ask | 71.56 x 800 |
| Day's Range | 68.96 - 71.18 |
| 52 Week Range | 61.01 - 82.27 |
| Volume | 3,367,096 |
| Avg. Volume | 2,730,042 |
| Market Cap | 22.035B |
| Beta (3Y Monthly) | 1.29 |
| PE Ratio (TTM) | 21.26 |
| EPS (TTM) | 3.34 |
| Earnings Date | Aug 12, 2019 - Aug 16, 2019 |
| Forward Dividend & Yield | 0.66 (0.94%) |
| Ex-Dividend Date | 2019-07-01 |
| 1y Target Est | 82.36 |
- Motley Fool
Agilent Keeps Analysts Guessing, Beats Estimates in Q3
The company has revised guidance in each of the last four quarters, but it continues to outperform expectations.
- Zacks
Tencent (TCEHY) Q2 Earnings Beat Estimates, Revenues Up Y/Y
Tencent's (TCEHY) second-quarter 2019 results benefit from robust FinTech and Business Services revenues despite sluggish ad environment in China.
- Zacks
Agilent (A) Upgraded to Buy: Here's Why
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
- Zacks
Agilent (A) Jumps: Stock Rises 6.1%
Agilent (A) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
- Motley Fool
Why Pivotal Software, Perspecta, and Agilent Technologies Jumped Today
Positive news helped these stocks break free from a volatile market and surge higher.
- Motley Fool
Here's Why Agilent Technologies Rose as Much as 10.8% Today
The lab hardware company reported fiscal third-quarter 2019 operating results.
- Business Wire
Agilent Introduces Revolutionary Real-Time Cell Analyzer
Multiplex assay combines non-invasive biosensor measurement with live cell imaging
- Business Wire
Agilent Presents Thought Leader Award to Professor Gang Yu
Agilent Technologies Inc. (NYSE:A) today announced that Dr. Gang Yu, a professor at the School of Environment at Tsinghua University in Beijing, China, has received an Agilent Thought Leader Award. The award recognizes his contributions towards understanding the problems caused by emerging organic contaminants in water, and the development of solutions to combat these problems. Professor Yu is also director of Beijing Key Laboratories for Emerging Organic Contaminants Control, and director of Tsinghua Research Center on Persistent Organic Pollutants.
- Zacks
Agilent (A) Earnings and Revenues Beat Estimates in Q3
Agilent (A) reports solid fiscal third-quarter results driven by strength in all its revenue segments.
- TheStreet.com
[video]Agilent Technologies Rises on Earnings Beat
Shares of Agilent Technologies gain after the company reports fiscal third-quarter profit and sales above expectations, and also raises its guidance for the year amid what it expects to be continued strong sales.
- Thomson Reuters StreetEvents
Edited Transcript of A earnings conference call or presentation 14-Aug-19 8:30pm GMT
Q3 2019 Agilent Technologies Inc Earnings Call
Motley FoolAgilent Technologies Inc (A) Q3 2019 Earnings Call Transcript
A earnings call for the period ending June 30, 2019.
- Zacks
Agilent Technologies (A) Tops Q3 Earnings and Revenue Estimates
Agilent (A) delivered earnings and revenue surprises of 5.56% and 2.85%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
- MarketWatch
Agilent stock rises after earnings beat, raised guidance
Shares of Agilent Technologies Inc. rose more than 5% in the extended session Wednesday after the maker of lab instruments and other components reported fiscal third-quarter profit and sales above Wall Street expectations and tweaked its guidance for the year. Agilent said it earned $1.27 billion, or 60 cents a share, in the quarter, compared with $236 million, or 73 cents a share, in the year-ago period. Adjusted for one-time items, Agilent earned $240 million, or 76 cents a share, compared with $217 million, or 67 cents a share, a year ago. Revenue rose 6% to $1.27 billion. Analysts polled by FactSet had expected Agilent to report adjusted earnings of 72 cents a share on sales of $1.24 billion. For fiscal 2019, Agilent raised its revenue guidance to a range between $5.105 billion and $5.125 billion, and its full-year non-GAAP EPS to a range between $3.07 and $3.09 a share. Agilent ended the regular trading day down 3%.
- Business Wire
Agilent Technologies Reports Third Quarter Fiscal Year 2019 Financial Results
Highlights:
- Investing.com
Agilent Technologies Earnings, Revenue Beat in Q3
Investing.com - Agilent Technologies (NYSE:A) reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
- Zacks
Wall Street Tumbles Following Yield Curve Inversion
Wall Street Tumbles Following Yield Curve Inversion
- Zacks
Stock Futures Plunge as Recession Fears Intensify
U.S. stock futures plummeted ahead of trading on Wednesday after a key Treasury yield curve inverted signaling an impending recession.
- Benzinga
Q3 Earnings Preview For Agilent Technologies
Agilent Technologies (NYSE: A ) unveils its next round of earnings this Wednesday, August 14. Get prepared with Benzinga's ultimate preview for Agilent Technologies's Q3 earnings. Earnings and Revenue ...
- American City Business Journals
The $200K Club: NetApp's median employee gets a pay boost to join the salary ranks of Google, Netflix and Facebook
NetApp Inc. this year paid its median employee just shy of $200,000 — a level that puts it on par with some of Silicon Valley's biggest companies and represents a 26 percent jump, year-over-year.
- Simply Wall St.
A Look At The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Does the August share price for Agilent Technologies, Inc. (NYSE:A) reflect what it's really worth? Today, we will...
- Zacks
Agilent (A) Gears Up for Q3 Earnings: What's in the Cards?
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal third-quarter 2019 results.
- Zacks
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Acquisition Boosts Exact Sciences' Role in Cancer Diagnostics
Purchase of Genomic Health expands testing capabilities and R&D; Continue reading...
- Business Wire
Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC)
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients
